Poly (3‐hydroxybutyrate‐co‐3‐hydroxyhexanoate) scaffolds coated with PhaP‐RGD fusion protein promotes the proliferation and chondrogenic differentiation of human umbilical cord mesenchymal stem cells in vitro
- 7 July 2014
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 103 (3) , 1169-1175
Abstract
Human umbilical cord blood‐derived mesenchymal stem cells (hUC‐MSCs) have been widely used in tissue engineering. The aim of this study is to evaluate the ability of poly (3‐hydroxybutyrate‐co‐3‐hydroxyhexanoate) (PHBHHx) scaffolds coated with polyhydroxyalkanoate binding protein fused with arginyl‐glycyl‐aspartic acid (PhaP‐RGD) to promote the proliferation and chondrogenic differentiation of hUC‐MSCs seeded on them. The PhaP‐RGD fusion protein was expressed byEscherichia coli. PHBHHx films were coated with PhaP‐RGD fusion protein and the physiochemical properties were examined. hUC‐MSCs were seeded on PHBHHx films with or without PhaP‐RGD precoating and tested for changes in morphology, viability, and chondrogenic differentiation. We found that PhaP‐RGD‐coated PHBHHx films had similar surface morphology to uncoated PHBHHx. The water contact angle of the coated PHBHHx surface was lower than that of the uncoated surface (10.63° vs. 98.69°). At 7 and 14 days after seeding, the PhaP‐RGD‐coated PHBHHx group showed greater numbers of viable cells compared to the uncoated PHBHHx group. The expression levels of aggrecan and collagen II were enhanced in the PhaP‐RGD‐coated PHBHHx group relative to the uncoated PHBHHx group. Histological analysis using toluidine blue staining showed elevated formation of proteoglycan producing chondrocytes in the PhaP‐RGD‐coated PHBHHx group. Additionally, the synthesis of proteoglycan and collagen was significantly enhanced within the PhaP‐RGD constructs. Taken together, PhaP‐RGD coating promotes the proliferation and chondrogenic differentiation of hUC‐MSCs seeded on PHBHHx films. PhaP‐RGD‐coated PHBHHx may be a useful scaffold for cartilage tissue engineering. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1169–1175, 2015.Keywords
Funding Information
- Natural Science Foundation of China (81000416)
- Fundamental Research Funds for the Central Universities (2011, 2012, 2013)
- Second Hospital of Xi'an Jiaotong University of China (RC(XM)201102, YJ(ZD)201301)
This publication has 20 references indexed in Scilit:
- Comparative Analysis of Human Mesenchymal Stem Cells from Bone Marrow, Adipose Tissue, and Umbilical Cord Blood as Sources of Cell TherapyInternational Journal of Molecular Sciences, 2013
- Osteoblastic potency of bone marrow cells cultivated on functionalized biometals with cyclic RGD‐peptideJournal of Biomedical Materials Research Part A, 2013
- Chondrogenic differentiation of human bone marrow mesenchymal stem cells on polyhydroxyalkanoate (PHA) scaffolds coated with PHA granule binding protein PhaP fused with RGD peptideBiomaterials, 2011
- The improvement of fibroblast growth on hydrophobic biopolyesters by coating with polyhydroxyalkanoate granule binding protein PhaP fused with cell adhesion motif RGDBiomaterials, 2010
- The effect of the addition of a polyglutamate motif to RGD on peptide tethering to hydroxyapatite and the promotion of mesenchymal stem cell adhesionBiomaterials, 2005
- The application of polyhydroxyalkanoates as tissue engineering materialsBiomaterials, 2005
- Effects of surface modification of poly (3‐hydroxybutyrate‐co‐3‐hydroxyhexanoate) (PHBHHx) on physicochemical properties and on interactions with MC3T3‐E1 cellsJournal of Biomedical Materials Research Part A, 2005
- Design of porous scaffolds for cartilage tissue engineering using a three-dimensional fiber-deposition techniqueBiomaterials, 2004
- A Repressor Protein, PhaR, Regulates Polyhydroxyalkanoate (PHA) Synthesis via Its Direct Interaction with PHAJournal of Bacteriology, 2002
- Tissue response and in vivo degradation of selected polyhydroxyacids: Polylactides (PLA), poly(3‐hydroxybutyrate) (PHB), and poly(3‐hydroxybutyrate‐co‐3‐hydroxyvalerate) (PHB/VA)Journal of Biomedical Materials Research, 1993